Novel and improved technologies for tuberculosis diagnosis: progress and challenges.
about
Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistanceScreening strategies for active tuberculosis: focus on cost-effectivenessCombating Tuberculosis Infection: A Forbidding ChallengeVaccines for TB: Lessons from the Past Translating into Future PotentialsClinical research and development of tuberculosis diagnostics: moving from silos to synergyComparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective studyClinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samplesAccurate and effective multidrug-resistant Mycobacterium tuberculosis detection method using gap-filling ligation coupled with high-resolution capillary electrophoresis-based single strand conformation polymorphism.Initial experience with GeneXpert MTB/RIF assay in the Arkansas Tuberculosis Control Program.Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence populationEvaluation of Cepheid's Xpert MTB/Rif test on pleural fluid in the diagnosis of pleural tuberculosis in a high prevalence HIV/TB settingComparison of the efficacies of loop-mediated isothermal amplification, fluorescence smear microscopy and culture for the diagnosis of tuberculosis.A comparison of multidrug-resistant tuberculosis treatment commencement times in MDRTBPlus line probe assay and Xpert® MTB/RIF-based algorithms in a routine operational setting in Cape Town.Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysisLipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuriaFactors associated with latent tuberculosis among asylum seekers in Switzerland: a cross-sectional study in Vaud County.Smear positive extra pulmonary tuberculosis disease at University of Gondar Hospital, Northwest EthiopiaSelected culture and drug-susceptibility testing methods for drug-resistant Mycobacterium tuberculosis screening in resource-constrained settings.The BCG World Atlas: a database of global BCG vaccination policies and practices.Current concepts in the management of tuberculosisEffect of Diagnostic and Treatment Delay on the Risk of Tuberculosis Transmission in Shenzhen, China: An Observational Cohort Study, 1993-2010Evaluation of in-house polymerase chain reaction assay sensitivity, can it be utilized in limited-resources settings?Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunitiesEvaluating tuberculosis case detection via real-time monitoring of tuberculosis diagnostic servicesTuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis.Adjunctive tests for diagnosis of tuberculosis: serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspirationUse of real time polymerase chain reaction for detection of M. tuberculosis, M. avium and M. kansasii from clinical specimens.Diagnosis of tuberculosis: the experience at a specialized diagnostic laboratoryPathogenesis and prevention of immune reconstitution disease during antiretroviral therapy.Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay.Host Protein Biomarkers Identify Active Tuberculosis in HIV Uninfected and Co-infected Individuals.Direct matrix-assisted laser desorption ionisation time-of-flight mass spectrometry identification of mycobacteria from colonies.Tuberculosis diagnostics: Challenges and opportunitiesThe impact of new tuberculosis diagnostics on transmission: why context matters.Comparison of four DNA extraction methods for detecting Mycobacterium tuberculosis by real-time PCR and its clinical application in pulmonary tuberculosis.Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis.Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa.Efficacy and safety of recombinant Mycobacterium tuberculosis ESAT-6 protein for diagnosis of pulmonary tuberculosis: a phase II trial.GeneXpert MTB/RIF Testing in the Management of Patients with Active Tuberculosis; A Real Life Experience from Saudi Arabia
P2860
Q22241307-96C93687-0AFD-4CA4-BE24-13FDE218C388Q26740226-296B4A82-165C-4F00-B0F9-A195AAC53C8FQ26750683-9FE3B46B-5ECC-48C1-8533-98A61AD87EBCQ26996673-4F8F610D-B2B8-4222-A9A8-C77FF87E3EDDQ28383710-4CAC82F8-F576-4BD5-9F26-84660BB69F81Q28479276-74EA95DF-F22D-44E4-8269-92935DD7D9CBQ33547441-12E2B022-DC35-4D75-98EF-8835917090EBQ33576611-6B7F6247-E4EE-4D83-9AB0-D54EB1223B21Q33737124-9751ECF1-7124-40BA-8C99-E305513C63D3Q33798016-801BB884-172D-4704-802D-821487538F9EQ33933436-3A355657-FA58-4C4B-B37A-4A9B36573622Q33939165-4F003824-89ED-4153-97E5-7B78369CD332Q33982095-45246C2B-5A4B-43E8-AFA5-7AF33BC69426Q33998704-CD87E206-F561-4F6E-98BE-2912C08667CEQ34173643-2B99D329-4AF7-4149-9DC3-B3F676921F86Q34465791-D5EFEF9D-D201-4FDE-B37E-26531090E21DQ34554312-E67875CB-74DE-44C4-88A0-5E5E13E43ED9Q34660618-6AA39DBA-C34E-4B93-8FEC-ED27CAE0F050Q34708175-419E9C3C-EAFF-4331-BF20-81D9D438AD68Q34748542-CB99E0B7-D571-40D8-9E10-18F7E648271CQ34797322-740A7D50-AF62-4F28-9782-20F9387696B6Q35036744-E29E40E6-CE91-4EC1-94DE-4CEAE0F6A10AQ35066020-977677B9-7E2C-4AE5-92A6-D315AE3FFE92Q35219731-83CC1F59-C88C-4248-A31E-ECBF4C0011ACQ35336481-6BE5D56A-66FA-4103-91B0-22154FB712A9Q35336560-2C9AAB8C-EF52-4063-B41F-0C6E6ED6C57DQ35584136-0C74A156-F49C-437A-B5BB-B8B626EBA213Q35586498-46D799F5-62ED-4902-A33C-99AE096ACE16Q35656939-AB1951F1-F91E-4609-B6C0-F880065F29DEQ35890799-98757569-8EA1-4AF5-83E4-664647B06741Q36062867-95587D5F-48DA-4019-844C-160E5AAA7FA2Q36106333-D4B3ACDA-15FB-4630-B3AD-8738C9E8D73AQ36109423-843BBB97-8D07-47F1-9FD4-9A0D54307C3BQ36181008-416A820C-9BFD-45C2-868A-94A096A7BBE1Q36316501-D526A98E-88A8-404A-9449-ADA8E048B4DDQ36972936-FA2131BF-A316-4826-836B-C7FDDC69B5C5Q37249425-26141DD8-52C9-42A4-AFC3-0EA954C06079Q37285167-9FD72EB5-9F1B-48AA-97AA-F403C5458CE2Q37332562-E1EC584D-547A-4E8C-9077-43E01633725AQ37673489-C11B6DA7-E361-4923-83BA-321316A5A80B
P2860
Novel and improved technologies for tuberculosis diagnosis: progress and challenges.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Novel and improved technologies for tuberculosis diagnosis: progress and challenges.
@en
Novel and improved technologies for tuberculosis diagnosis: progress and challenges.
@nl
type
label
Novel and improved technologies for tuberculosis diagnosis: progress and challenges.
@en
Novel and improved technologies for tuberculosis diagnosis: progress and challenges.
@nl
prefLabel
Novel and improved technologies for tuberculosis diagnosis: progress and challenges.
@en
Novel and improved technologies for tuberculosis diagnosis: progress and challenges.
@nl
P2093
P1476
Novel and improved technologies for tuberculosis diagnosis: progress and challenges.
@en
P2093
Alice Zwerling
Hojoon Sohn
Jessica Minion
Mark D Perkins
P304
701-16, viii
P356
10.1016/J.CCM.2009.08.016
P50
P577
2009-12-01T00:00:00Z